(Q30311870)

16 June 2017

1 reference

title

Oral budesonide in the management of Crohn's disease (English)

1 reference

16 June 2017

Oral Budesonide in the Management of Crohn's Disease (English)

1 reference

16 March 2024

0 references

Kristi N. Hofer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14519035

16 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

full work available at URL

16 June 2017

http://journals.sagepub.com/doi/pdf/10.1345/aph.1D059

1 reference

http://journals.sagepub.com/doi/full-xml/10.1345/aph.1D059

16 March 2024

1 reference

Annals of Pharmacotherapy

16 March 2024

published in

1 reference

16 June 2017

37

1 reference

16 June 2017

10

1 reference

16 June 2017

1457-1464

1 reference

Management of Crohn's disease in adults

16 June 2017

1 reference

Budesonide. An updated review of its pharmacological properties, and therapeutic efficacy in asthma and rhinitis

21 January 2018

1 reference

Budesonide. A review of its pharmacological properties and therapeutic efficacy in inflammatory bowel disease

21 January 2018

1 reference

Review article: issues in oral administration of locally acting glucocorticosteroids for treatment of inflammatory bowel disease

21 January 2018

1 reference

Effect of food on the pharmacokinetics of budesonide controlled ileal release capsules in patients with active Crohn's disease

21 January 2018

1 reference

Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group

21 January 2018

1 reference

Budesonide CIR capsules (once or twice daily divided-dose) in active Crohn's disease: a randomized placebo-controlled study in the United States

21 January 2018

1 reference

Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group

21 January 2018

1 reference

A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group.

21 January 2018

1 reference

Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study

21 January 2018

1 reference

Oral budesonide as maintenance therapy in Crohn's disease--results of a 12-month study. Global Budesonide Study Group.

21 January 2018

1 reference

Maintenance of Crohn's disease over 12 months: fixed versus flexible dosing regimen using budesonide controlled ileal release capsules

21 January 2018

1 reference

Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease

21 January 2018

1 reference

Bone turnover during short-term therapy with methylprednisolone or budesonide in Crohn's disease

21 January 2018

1 reference

Bone mineral density in Crohn's disease: a longitudinal study of budesonide, prednisone, and nonsteroid therapy

21 January 2018

1 reference

Drug Points: Anaphylactic-like reaction associated with oral budesonide

21 January 2018

1 reference

Reduction of the inhibitory effect of ketoconazole on budesonide pharmacokinetics by separation of their time of administration.

21 January 2018

1 reference

Controlled ileal release budesonide in pediatric Crohn disease: efficacy and effect on growth

21 January 2018

1 reference

Budesonide versus prednisone in the treatment of active Crohn's disease. The Israeli Budesonide Study Group

21 January 2018

8

1 reference

16 March 2024

Molecular Pharmacology

10

25

70

Dahlberg E

1984

1 reference

A comparison of budesonide with prednisolone for active Crohn's disease

16 March 2024

17

1 reference

Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group

16 March 2024

20

1 reference

Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group

16 March 2024

26

1 reference

Effect of an oral contraceptive on the plasma levels of budesonide and prednisolone and the influence on plasma cortisol

16 March 2024

34

1 reference

Cushing's syndrome in an 81-year-old patient treated with budesonide and amiodarone

16 March 2024

35

1 reference

16 March 2024

Identifiers

DOI

10.1345/APH.1D059

1 reference

16 June 2017

1 reference